No AKI | AKI (renal replacement) | p-value | |
---|---|---|---|
Baseline | |||
Male% (n) | 64(40) | 75(6) | 0.79 |
Age ys | 72.6 ± 10.1 | 80 ± 3.7ys | 0.003 |
Weight kg | 83 ± 15 | 87 ± 14 | 0.51 |
Baseline Crea mg/dl | 1.09 ± 0.3 | 1.6 ± 0.84 | 0.13 |
Baseline GFR stage | 2.2 ± 0,6 | 2.25 ± 0,6 | 0.8 |
Elective% (n) | 100(62) | 100(8) | |
ASA class ≥II% (n) | 34(21) | 62(5) | 0.13 |
Diabetes% (n) | 29(18) | 37(3) | 0.45 |
LV function reduced% (n) | 53(33) | 37(3) | 0.47 |
Surgical data | |||
Bypass time min | 116 ± 39 | 155 ± 38 | 0.01 |
Cross-clamp time min | 72 ± 32 | 102 ± 36 | 0.02 |
Urine output on bypass ml | 360 ± 290 | 315 ± 310 | 0.32 |
Post-filtration CPB% (n) | 8(5) | 37(3) | |
CABG% (n) | 62(39) | 25(2) | 0.05 |
Postoperative data | |||
Fluid balance 24 h ml | 1103 ± 1026 | 1403 ± 860 | 0.001 |
Furosemide total dose 48 h (mg) | 90 ± 60 | 98 ± 65 | 0.4 |
Secondary outcome | |||
Length ICU stay d | 1,58 ± 1.89 | 23.25 ± 20.88 | 0.000 |
Length hospital stay d | 11 ± 5.9 | 30.6 ± 19.1 | 0.000 |
Mortality 30d% (n) | 6.4(4) | 25(2) | 0.1 |